Efficacy of inferior vesical vessels preservation in lateral lymph node dissection for rectal cancer: Short- and long-term outcomes

被引:0
|
作者
Arai, Sodai [1 ,2 ]
Kagawa, Hiroyasu [1 ,2 ]
Shiomi, Akio [1 ]
Manabe, Shoichi [1 ]
Yamaoka, Yusuke [1 ]
Maeda, Chikara [1 ]
Tanaka, Yusuke [1 ]
Kasai, Shunsuke [1 ,2 ]
Notsu, Akifumi [3 ]
Kinugasa, Yusuke [2 ]
机构
[1] Shizuoka Canc Ctr, Div Colon & Rectal Surg, 1007 Shimonagakubo,Nagaizumi Cho, Shizuoka 4118777, Japan
[2] Inst Sci Tokyo, Dept Gastrointestinal Surg, Tokyo, Japan
[3] Shizuoka Canc Ctr, Clin Res Ctr, Shizuoka, Japan
关键词
inferior vesical vessels; lateral lymph node dissection; rectal cancer; robotic surgery; urinary dysfunction; MESORECTAL EXCISION; CLASSIFICATION; DYSFUNCTION; BLADDER; SYSTEM;
D O I
10.1111/codi.70029
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: Lateral lymph node dissection (LLD) is performed for rectal cancer, with some cases requiring resection of the inferior vesical vessels (IVV). However, whether preservation or resection of the IVV affects urinary dysfunction (UD) as a major complication or local recurrence (LR) is unclear. Thus, we assessed the effect of IVV resection on the short- and long-term outcomes of rectal cancer. Method: This retrospective cohort study included patients who underwent robotic mesorectal excision with LLD between December 2011 and April 2021. The patients were divided into two groups based on preserved and resected IVV. Postoperative complications, including UD, and long-term outcomes, including cumulative LR and cumulative lateral local recurrence (LLR), were evaluated. Results: Among 340 patients, 298 (87.6%) and 42 (12.4%) were included in the IVV preservation and resection groups, respectively. UD was more frequent (50% vs. 16.8%) in the IVV resection group than in the IVV preservation group (p < 0.01). In the multivariate analysis, IVV and autonomic nervous system resections were significantly associated with UD. The 3-year LR was 4.0% and 5.7% in the IVV preservation and resection groups, respectively (p = 0.99). The 3-year LLR was 2.1% and 0% in the IVV preservation and resection groups, respectively (p = 0.27). Conclusion: IVV resection and autonomic nervous system resection were independent risk factors for UD in robotic LLD. IVV preservation, except in cases of necessity, improves patients' quality of life and has favourable oncological outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Fascia- vs vessel-oriented lateral lymph node dissection for rectal cancer: Short-term outcomes and prognosis in a single-center experience
    Zhao, Wei
    Wang, Zhi-Jie
    Mei, Shi-Wen
    Chen, Jia-Nan
    Zhou, Si-Cheng
    Zhao, Fu-Qiang
    Xiao, Ti-Xian
    Huang, Fei
    Liu, Qian
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (06): : 1080 - 1092
  • [42] Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer
    Kawai, Kazushige
    Shiratori, Hiroshi
    Hata, Keisuke
    Nozawa, Hiroaki
    Tanaka, Toshiaki
    Nishikawa, Takeshi
    Murono, Koji
    Ishihara, Soichiro
    DISEASES OF THE COLON & RECTUM, 2021, 64 (03) : 274 - 283
  • [43] Short- and Long-Term Outcomes of Robotic Surgery for Rectal Neuroendocrine Tumor
    Saito, Kentaro
    Yamaoka, Yusuke
    Shiomi, Akio
    Kagawa, Hiroyasu
    Hino, Hitoshi
    Manabe, Shoichi
    Kato, Shunichiro
    Hanaoka, Marie
    SURGICAL INNOVATION, 2022, 29 (03) : 315 - 320
  • [44] The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis
    Ma, Peilan
    Yuan, Yuan
    Yan, Peijing
    Chen, Guohua
    Ma, Shixun
    Niu, Xiangdong
    Xu, Meng
    Yang, Kehu
    Cai, Hui
    ASIAN JOURNAL OF SURGERY, 2020, 43 (09) : 891 - 901
  • [45] Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis
    Sicheng Zhou
    Yujuan Jiang
    Jianwei Liang
    Qian Liu
    World Journal of Surgical Oncology, 20
  • [46] Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
    Ishibe, Atsushi
    Watanabe, Jun
    Suwa, Yusuke
    Suzuki, Shinsuke
    Nakagawa, Kazuya
    Suwa, Hirokazu
    Ozawa, Mayumi
    Ota, Mitsuyoshi
    Fujii, Shoichi
    Ike, Hideyuki
    Ichikawa, Yasushi
    Endo, Itaru
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (02) : 293 - 301
  • [47] Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
    Atsushi Ishibe
    Jun Watanabe
    Yusuke Suwa
    Shinsuke Suzuki
    Kazuya Nakagawa
    Hirokazu Suwa
    Mayumi Ozawa
    Mitsuyoshi Ota
    Shoichi Fujii
    Hideyuki Ike
    Yasushi Ichikawa
    Itaru Endo
    International Journal of Colorectal Disease, 2021, 36 : 293 - 301
  • [48] Neoadjuvant chemoradiotherapy for borderline resectable low rectal cancer: short- and long-term outcomes at a single Japanese center
    Hitoshi Hino
    Akio Shiomi
    Hiroyasu Kagawa
    Shoichi Manabe
    Yusuke Yamaoka
    Shunichiro Kato
    Marie Hanaoka
    Surgery Today, 2022, 52 : 1072 - 1080
  • [49] Short- and long-term outcomes of robotic surgery for rectal cancer: a single-center retrospective cohort study
    Katsuno, Hidetoshi
    Hanai, Tsunekazu
    Masumori, Koji
    Koide, Yoshikazu
    Matsuoka, Hiroshi
    Tajima, Yosuke
    Endo, Tomoyoshi
    Mizuno, Masahiro
    Chong, Yongchol
    Maeda, Kotaro
    Uyama, Ichiro
    SURGERY TODAY, 2020, 50 (03) : 240 - 247
  • [50] Neoadjuvant chemoradiotherapy for borderline resectable low rectal cancer: short- and long-term outcomes at a single Japanese center
    Hino, Hitoshi
    Shiomi, Akio
    Kagawa, Hiroyasu
    Manabe, Shoichi
    Yamaoka, Yusuke
    Kato, Shunichiro
    Hanaoka, Marie
    SURGERY TODAY, 2022, 52 (07) : 1072 - 1080